GlaxoSmithKline PLC will pay $6 million to resolve a lawsuit by Louisiana alleging it illegally tried to delay generic versions of its allergy spray Flonase, ending the drugmaker's appeal to the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback